About 76 Trademarks found that are owned by Mitsubishi Tanabe Pharma Corporation

Pharmaceutical preparations for the treatment of Parkinson's disease

Pharmaceutical preparations for the treatment of Parkinson's disease

Pharmaceutical preparations for the treatment of Parkinson's disease

Color is not claimed as a feature of the mark.

The wording "RADICAVA" has no meaning in a foreign language.

Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

The mark consists of a stylized design of a hand.

Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, ] neurological [, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders [ ; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction ]

Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

Pharmaceutical preparations for the treatment of Parkinson's disease

Pharmaceutical preparations for treatment of porphyrin metabolism disorders; pharmaceutical preparations for treatment of porphyria; pharmaceutical preparations for treatment of photodermatoses; pharmaceutical preparations for treatment of scleroderma